Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.

Saved in:
Bibliographic Details
Title: Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.
Authors: Stahl M; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and.; German Center for Lung Research, Associated Partner Site, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany., Roehmel J; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and., Eichinger M; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, and., Doellinger F; Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Naehrlich L; Department of Pediatrics, Justus Liebig University Giessen, Giessen, Germany.; Universities of Giessen and Marburg Lung Center, German Center for Lung Research, Giessen, Germany., Kopp MV; Pediatric Respiratory Medicine, Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland.; Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany., Dittrich AM; Department for Pediatric Pulmonology, Allergology, and Neonatology and.; BREATH, German Center for Lung Research, Hannover Medical School, Hannover, Germany; and., Lee C; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Sommerburg O; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center, Department of Pediatrics, Heidelberg University Hospital, Heidelberg, Germany., Tian S; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Xu T; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Wu P; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Joshi A; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Ray P; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Duncan ME; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts., Wielpütz MO; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, and., Mall MA; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and.; German Center for Lung Research, Associated Partner Site, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Source: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2023 Aug; Vol. 20 (8), pp. 1144-1155.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36943405
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stahl+M%22">Stahl M</searchLink>; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and.; German Center for Lung Research, Associated Partner Site, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Roehmel+J%22">Roehmel J</searchLink>; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and.<br /><searchLink fieldCode="AU" term="%22Eichinger+M%22">Eichinger M</searchLink>; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, and.<br /><searchLink fieldCode="AU" term="%22Doellinger+F%22">Doellinger F</searchLink>; Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Naehrlich+L%22">Naehrlich L</searchLink>; Department of Pediatrics, Justus Liebig University Giessen, Giessen, Germany.; Universities of Giessen and Marburg Lung Center, German Center for Lung Research, Giessen, Germany.<br /><searchLink fieldCode="AU" term="%22Kopp+MV%22">Kopp MV</searchLink>; Pediatric Respiratory Medicine, Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland.; Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22Dittrich+AM%22">Dittrich AM</searchLink>; Department for Pediatric Pulmonology, Allergology, and Neonatology and.; BREATH, German Center for Lung Research, Hannover Medical School, Hannover, Germany; and.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sommerburg+O%22">Sommerburg O</searchLink>; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center, Department of Pediatrics, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Tian+S%22">Tian S</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Xu+T%22">Xu T</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wu+P%22">Wu P</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Joshi+A%22">Joshi A</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ray+P%22">Ray P</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Duncan+ME%22">Duncan ME</searchLink>; Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wielpütz+MO%22">Wielpütz MO</searchLink>; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, and.<br /><searchLink fieldCode="AU" term="%22Mall+MA%22">Mall MA</searchLink>; Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine and.; German Center for Lung Research, Associated Partner Site, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101600811%22">Annals of the American Thoracic Society</searchLink> [Ann Am Thorac Soc] 2023 Aug; Vol. 20 (8), pp. 1144-1155.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101600811 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2325-6621 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223256621%22">23256621 </searchLink><i>NLM ISO Abbreviation: </i>Ann Am Thorac Soc <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36943405
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1513/AnnalsATS.202208-684OC
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1144
    Titles:
      – TitleFull: Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stahl M
      – PersonEntity:
          Name:
            NameFull: Roehmel J
      – PersonEntity:
          Name:
            NameFull: Eichinger M
      – PersonEntity:
          Name:
            NameFull: Doellinger F
      – PersonEntity:
          Name:
            NameFull: Naehrlich L
      – PersonEntity:
          Name:
            NameFull: Kopp MV
      – PersonEntity:
          Name:
            NameFull: Dittrich AM
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: Sommerburg O
      – PersonEntity:
          Name:
            NameFull: Tian S
      – PersonEntity:
          Name:
            NameFull: Xu T
      – PersonEntity:
          Name:
            NameFull: Wu P
      – PersonEntity:
          Name:
            NameFull: Joshi A
      – PersonEntity:
          Name:
            NameFull: Ray P
      – PersonEntity:
          Name:
            NameFull: Duncan ME
      – PersonEntity:
          Name:
            NameFull: Wielpütz MO
      – PersonEntity:
          Name:
            NameFull: Mall MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2325-6621
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Annals of the American Thoracic Society
              Type: main
ResultId 1